Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$56.5M
+6.4% from 2023
Prescriptions
9,621
$5,868.34 per claim
Patients
1,477
1,521 prescribers
Total spending, 2024
$56.5M
$38,225.64 per patient
Medicare prescription drug plans paid $56.5M for Sandostatin Lar Depot in 2024, for 9,621 prescriptions and refills to 1,477 patients (up 6.4% from 2023). The average cost per claim was $5,868.34.
New York had the highest Medicare cost for Sandostatin Lar Depot in 2024: $7.4M for 1,364 claims, followed by California ($5.0M).
Charles Famoyin, general practice in Johnson City, TN, had the highest Medicare cost for Sandostatin Lar Depot in 2024: 45 claims costing $481K.
Sandostatin Lar Depot is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Charles Famoyin Johnson City, TN | General Practice | 45 | Under 11 | $481K |
| John B Rhodes Jr. Lafayette, LA | Gastroenterology | 87 | 12 | $389K |
| Manish Dhawan |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,351 | 8,662 | 1,261 | $52.0M |
| 2023 | 1,274 | 8,745 | 1,252 | $53.1M |
| 2024 | 1,521 | 9,621 | 1,477 | $56.5M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 77 |
| 15 |
| $386K |
| Laurel R Fisher Philadelphia, PA | Gastroenterology | 72 | Under 11 | $377K |
| Daniel Lebovic Grosse Pointe Woods, MI | Hematology-Oncology | 52 | Under 11 | $309K |
| Peter J Snyder Philadelphia, PA | Internal Medicine | 28 | Under 11 | $306K |
| Dirk C Davidson Crossville, TN | Medical Oncology | 50 | Under 11 | $296K |
| Ashvini Sengar Gadsden, AL | Hematology-Oncology | 46 | Under 11 | $289K |
| David F Martin Pinehurst, NC | Gastroenterology | 30 | Under 11 | $280K |
| Jimmy J Hwang Charlotte, NC | Hematology-Oncology | 14 | Under 11 | $280K |
| Renu Joshi Mechanicsburg, PA | Endocrinology | 13 | Under 11 | $258K |
| Frederick L Flynt Jr. Athens, GA | Hematology-Oncology | 33 | Under 11 | $252K |
| Heather T Warren Philadelphia, PA | Nurse Practitioner | 32 | Under 11 | $215K |
| M Ashraf Meelu Waldorf, MD | Hematology-Oncology | 32 | Under 11 | $211K |
| Rodney F Pommier Portland, OR | Surgical Oncology | 38 | Under 11 | $201K |
| Qi Feng Brooklyn, NY | Hematology-Oncology | 31 | Under 11 | $200K |
| Mark E Drogowski Cheboygan, MI | Family Practice | 22 | Under 11 | $199K |
| Ratesh Khillan Brooklyn, NY | Medical Oncology | 46 | Under 11 | $199K |
| John del Valle Ann Arbor, MI | Gastroenterology | 17 | Under 11 | $194K |
| William R Mitchell Huntersville, NC | Hematology-Oncology | 35 | Under 11 | $182K |
| Ricardo H Alvarez Houston, TX | Internal Medicine | 13 | Under 11 | $179K |
| Samer Ballouz Royal Oak, MI | Medical Oncology | 13 | Under 11 | $174K |
| B A Bottenberg Carson City, NV | Internal Medicine | 13 | Under 11 | $173K |
| Joseph Kang Ventura, CA | Student in an Organized Health Care Education/Training Program | 12 | Under 11 | $169K |
| Rashid Cheema Danville, PA | Endocrinology | 19 | Under 11 | $168K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 9,621 | $56.5M |